Princess Maxima Center for Pediatric Oncology

• A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

  Collaborator, Phase 3, Recruiting, 130 people, 31 Oct 2025

• NCT07175415

  Phase 1/2, Not yet recruiting, 42 people, 16 Sept 2025

• NCT06262438

  Phase 2, Recruiting, 60 people, 16 Feb 2024

• NCT05751044

  Phase 1/2, Recruiting, 26 people, 2 Mar 2023

• NCT05745714

  Phase 1/2, Recruiting, 26 people, 27 Feb 2023

• NCT05740449

  Phase 1/2, Withdrawn, 0 people, 23 Feb 2023

• NCT05658640

  Phase 1/2, Recruiting, 26 people, 21 Dec 2022

• NCT05183035

  Collaborator, Phase 3, Recruiting, 130 people, 10 Jan 2022

Sources: clinicaltrials.gov